You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interferon alpha-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 22, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2022

Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

Not yet recruiting
  • Myelofibrosis
  • Pegylated interferon alpha2a
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 6, 2022

Coronavirus Disease 2019 Trial in Santiago (Interferon-Alpha2B, Placebo)

Completed
  • Coronavirus Disease 2019
  • Santiago, RM, Chile
    Red de Salud UC Christus
Aug 3, 2022

Hepatitis B Virus Trial in Beijing (Human Serum Albumin/interferon alpha2b fusion protein, Pegasys)

Completed
  • Hepatitis B Virus
  • Human Serum Albumin/interferon alpha2b fusion protein
  • Pegasys
  • Beijing, Beijing, China
    Beijing YouAn Hospital, Capital Medical University
Mar 29, 2021

Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)

Active, not recruiting
  • Chronic Hepatitis B
  • Birtinya, Queensland, Australia
  • +21 more
Dec 20, 2021

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Recruiting
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 18, 2021

Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

Recruiting
  • Hematological Neoplasms
  • Recurrence
  • Peg interferon alfa-2b
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
Has Results
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
Has Results
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

HIV Trial in United States (Interferon alfa-2a, Zidovudine)

Completed
  • HIV Infections
  • Los Angeles, California
  • +5 more
Oct 26, 2021

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

Terminated
  • Hepatitis B, Chronic
  • Hillsborough, New Jersey
  • +11 more
Jan 27, 2022

Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • Miami, Florida
    Univ of Miami School of Medicine
Oct 27, 2021

Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • New York, New York
    Mem Sloan - Kettering Cancer Ctr
Oct 28, 2021

Melanoma Trial in Houston (Temozolomide (TMZ), Pegylated Interferon Alpha-2b (PGI))

Completed
Has Results
  • Melanoma
  • Temozolomide (TMZ)
  • Pegylated Interferon Alpha-2b (PGI)
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 1, 2020

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 18, 2022

Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors Trial in Pittsburgh (Chemokin Modulatory Regimen (5 MU/m2), Chemokin

Terminated
Has Results
  • Colorectal Cancer
  • +3 more
  • Chemokin Modulatory Regimen (5 MU/m2)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 21, 2020

Melanoma Trial in Houston (Temozolomide, Velban, Cisplatin)

Terminated
Has Results
  • Melanoma
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Sep 1, 2020

Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)

Completed
  • Advanced Renal Cell Carcinoma
  • Pazopanib + interferon alpha 2A
  • Hospitalet de Llobregat, Barcelona, Spain
  • +12 more
Mar 9, 2022

Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2b, Zidovudine, Sargramostim)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2b
  • +2 more
  • New York, New York
    Mem Sloan - Kettering Cancer Ctr
Oct 26, 2021

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Sarcoma, Kaposi, HIV Trial in United States (Interferon alfa-2a, Zidovudine)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Miami, Florida
  • +8 more
Oct 26, 2021

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Chronic Phase of Chronic Myeloid Leukemia Trial (Dasatinib, Peg-Interferon alpha2b)

Completed
  • Chronic Phase of Chronic Myeloid Leukemia
  • (no location specified)
Feb 7, 2020